EUCTR2012-001032-57-BE进行中（未招募）1 期
Immunogenicity, Reactogenicity and Safety of the TrivalentInfluenza Subunit Vaccine Influvac® for the NorthernHemisphere Season 2012/2013. An Open-Label, Baseline-Controlled Study in Two Age Groups: Adult Subjects = 18 and= 60 Years and Elderly Subjects = 61 Years of Age. - Influvac Annual Update 2012/2013 study
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Willing and able to give informed consent and able to adhere to all protocol required study procedures.
- •2.Men and women aged = 18 and = 60 years or = 61 years of age at the day of study vaccination.
- •3.Being in good health as judged by medical history, physical examination (if needed) and clinical judgment of the Investigator.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 65
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 65
排除标准
- •1. Known to be allergic to eggs, chicken protein, gentamicin or any other constituent of the vaccine.
- •2. A serious adverse reaction after a previous (influenza) vaccination.
- •3. Presence of any significant condition that may prohibit inclusion as determined by the investigator.
- •4. Seasonal or pandemic influenza vaccination or laboratory confirmed seasonal or pandemic influenza infection within the previous six months before study vaccination or planned vaccination during the study period.
- •5. Having any condition which suppresses the immune system and autoimmune disorders.
研究者
相似试验
进行中（未招募）
1 期
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2013/2014 SeasoEUCTR2013-000881-12-BEAbbott Biologicals B.V130
进行中（未招募）
不适用
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasoEUCTR2012-001032-57-DEAbbott Biologicals B.V.130
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects = 18 and = 60 Years and Elderly Subjects = 61 Years of Age - Influvac Annual Update 2008/2009EUCTR2008-001038-28-BESolvay Biologicals BV120
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects = 18 and = 60 Years and Elderly Subjects = 61 Years of Age - Influvac Annual Update 2008/2009EUCTR2008-001038-28-DESolvay Biologicals BV120
进行中（未招募）
不适用
Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2010/2011. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects =18 and =60 Years and Elderly Subjects = 61 Years of Age. - Influvac Annual Update 2010/2011Prophylaxis of InfluenzaMedDRA version: 12.1Level: HLTClassification code 10022005Term: Influenza viral infectionsEUCTR2010-018350-13-BEAbbott Biologicals B.V.120